Trial intelligence / Profile preview

Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children with ADHD (ABC Study)

2015-001042-28Phase 4

Sponsor
Janssen Pharmaceutical
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Hour 4 Permanent Product Math Test Attempted Score (PERMP-Attempted).

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on 2015-001042-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-001042-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call